Management of oligometastatic/metastatic sarcomas and place of local treatments with focus on modern radiotherapy approaches.
Metastatic
Métastatique
Oligometastatic
Oligométastatique
Radiotherapy
Radiothérapie
Sarcoma
Sarcomes
Journal
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
ISSN: 1769-6658
Titre abrégé: Cancer Radiother
Pays: France
ID NLM: 9711272
Informations de publication
Date de publication:
10 Jan 2024
10 Jan 2024
Historique:
received:
14
04
2023
revised:
09
05
2023
accepted:
29
06
2023
medline:
12
1
2024
pubmed:
12
1
2024
entrez:
11
1
2024
Statut:
aheadofprint
Résumé
Soft tissue sarcomas are a rare and heterogeneous disease. For localized disease, treatment is based on surgery and radiotherapy with or without chemotherapy depending on risk factors. Upfront metastases are present in 7 to 20% of cases, and are localized to the lungs in most of cases. Disseminated disease is generally considered incurable but in selected cases, aggressive local treatment of metastases allowed long survival. Treatment of primary tumour is often debated. Our purpose is to evaluate the literature concerning the role of radiotherapy in the management of primary metastatic soft tissue sarcomas.
Identifiants
pubmed: 38212215
pii: S1278-3218(23)00222-6
doi: 10.1016/j.canrad.2023.06.029
pii:
doi:
Types de publication
Practice Guideline
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2023 Société française de radiothérapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.